You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address